AT-752
- Generic Name
- AT-752
Study of AT-752 in Patients With Dengue Infection
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Atea Pharmaceuticals, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT05466240
- Locations
- 🇻🇳
Atea Study Site, Hanoi, Vietnam
Study of AT-752 in Healthy Subjects in a Dengue Human Challenge Model
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Atea Pharmaceuticals, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT05366439
- Locations
- 🇺🇸
Atea Study Site, Syracuse, New York, United States
Study of AT-752 in Healthy Subjects
- First Posted Date
- 2021-01-25
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- Atea Pharmaceuticals, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT04722627
- Locations
- 🇦🇺
Atea Study Site, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath